Hard-hitting Therapies for Soft Tissue Cancers: New Treatment Approaches for Sarcomas
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are...
Category: Journals
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are...
For June, the editors of the AACR’s 10 journals chose to spotlight a characterization of an investigational KRAS inhibitor,...
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
This month’s selection of studies picked by the editors of the AACR journals includes a new bispecific antibody for...
In 2020, the COVID-19 pandemic was dominating the headlines, but CNN reporter Andrew Kaczynski was happy at home. He...
As we keep an eye out for those promised May flowers, we bring you the latest round of Editors’...
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...
This year, the American Association for Cancer Research (AACR) will celebrate its 115th birthday. From the very beginning, women...
For the first Editors’ Picks collection of 2022, the editors of the AACR journals highlighted studies that assessed the...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....